Verona Pharma Plc
VRNA
$73.93-1.68 (-2.22%)
May 28, 2025, 4:00 PM
Financials
| 52Week High | 76.92 | 52Week Low | 11.39 |
| Beta | 0.18 | Current Ratio Annual | 10.63 |
| Current Ratio Quarterly | 8.86 | Gross Margin TTM | 94.95 |
| Market Cap | 6.44B | Net Profit Margin TTM | -78.55 |
| Operating Margin TTM | -58.83 | Price To Book | 28.41 |
| Price To Sales TTM | 54.30 | Quick Ratio Annual | 10.30 |
| Quick Ratio Quarterly | 8.53 | Return On Assets TTM | -36.11 |
| Return On Equity TTM | -89.84 | Return On Investment TTM | -49.24 |
| Revenue Growth3Y | 1.86 | Revenue Per Share TTM | 0.17 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 201 | 1 | 0 | 1 | 4 | 0 | 70.26M | $3.06B |
| Mar 31, 2025 | 262 | 83 | 16 | 75 | 87 | 15 | 75.17M | $4.43B |
| Change | 61(30%) | 82(8200%) | 16 | 74(7400%) | 83(2075%) | 15 | 4.91M(7%) | $1.37B(45%) |